Title:
IGF1RおよびPI3Kに対する阻害剤の併用治療
Document Type and Number:
Japanese Patent JP2015524414
Kind Code:
A
Abstract:
本発明は、(S)−ピロリジン−1,2−ジカルボン酸2−アミド1−({4−メチル−5−[2−(2,2,2−トリフルオロ−1,1−ジメチル−エチル)−ピリジン−4−イル]−チアゾール−2−イル}−アミド)、またはその薬剤的に許容可能な塩などのαアイソフォーム特異性ホスファチジルイノシトール3−キナーゼ阻害剤化合物およびIGF1R阻害剤(例えば、IGF1R阻害剤抗体A、またはその変異体もしくは誘導体)を含む組み合せ医薬品、その組み合わせを含む医薬組成物、それを必要とする対象にその阻害剤の治療有効量を投与することを含む癌治療の方法、および癌治療のためのその組み合わせの使用に関する。
More Like This:
Inventors:
Sijong Juan
Marte Peters
Karl Maria Schumacher
Ju Alexander Khao
Jennifer Lorraine Gunsart
David Don Eun Chan
Marte Peters
Karl Maria Schumacher
Ju Alexander Khao
Jennifer Lorraine Gunsart
David Don Eun Chan
Application Number:
JP2015523289A
Publication Date:
August 24, 2015
Filing Date:
July 19, 2013
Export Citation:
Assignee:
Novartis Age
Amgen Incorporated
Amgen Incorporated
International Classes:
A61K45/06; A61K31/4439; A61K39/395; A61P15/00; A61P35/00; A61P35/02; A61P35/04; A61P43/00; C07K16/30
Domestic Patent References:
JP2012502080A | 2012-01-26 | |||
JP2008525034A | 2008-07-17 |
Foreign References:
WO2008079849A2 | 2008-07-03 |
Other References:
JEROEN C. VERHEIJEN: "PHOSPHATIDYLINOSITOL 3-KINASE (PI3K) INHIBITORS AS ANTICANCER DRUGS", DRUGS OF THE FUTURE, vol. V32 N6, JPN5015008512, 1 January 2007 (2007-01-01), pages 537 - 547, ISSN: 0003712214
WEE SUSAN: "CLASS IA PHOSPHOINOSITIDE 3-KINASE ISOFORMS AND HUMAN TUMORIGENESIS: 以下備考", CURRENT OPINION IN ONCOLOGY, vol. V20 N1, JPN5015008513, 1 January 2008 (2008-01-01), US, pages 77 - 82, ISSN: 0003712215
SAMUELS YARDENA: "ONCOGENIC PI3K AND ITS ROLE IN CANCER", CURRENT OPINION IN ONCOLOGY, vol. V18 N1, JPN5015008514, 1 January 2006 (2006-01-01), US, pages 77 - 82, ISSN: 0003712216
WEE SUSAN: "CLASS IA PHOSPHOINOSITIDE 3-KINASE ISOFORMS AND HUMAN TUMORIGENESIS: 以下備考", CURRENT OPINION IN ONCOLOGY, vol. V20 N1, JPN5015008513, 1 January 2008 (2008-01-01), US, pages 77 - 82, ISSN: 0003712215
SAMUELS YARDENA: "ONCOGENIC PI3K AND ITS ROLE IN CANCER", CURRENT OPINION IN ONCOLOGY, vol. V18 N1, JPN5015008514, 1 January 2006 (2006-01-01), US, pages 77 - 82, ISSN: 0003712216
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe
Shinya Mitsuhiro
Tatsuhiko Abe